| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8175 |
| Human Intestinal Absorption | HIA- | 0.8012 |
| Caco-2 Permeability | Caco2- | 0.8233 |
| P-glycoprotein Substrate | Non-substrate | 0.5083 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7178 |
| Non-inhibitor | 0.9345 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8041 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7180 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8797 |
| CYP450 2D6 Substrate | Non-substrate | 0.8465 |
| CYP450 3A4 Substrate | Non-substrate | 0.6276 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9264 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9165 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9206 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8336 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9221 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9247 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9221 |
| Non-inhibitor | 0.8966 |
| AMES Toxicity | Non AMES toxic | 0.8867 |
| Carcinogens | Non-carcinogens | 0.9553 |
| Fish Toxicity | High FHMT | 0.6844 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6961 |
| Honey Bee Toxicity | High HBT | 0.7438 |
| Biodegradation | Not ready biodegradable | 0.8500 |
| Acute Oral Toxicity | III | 0.4488 |
| Carcinogenicity (Three-class) | Non-required | 0.6978 |